XTANT MEDICAL Financials
XMS Stock | EUR 0.34 0.01 3.03% |
XTANT |
Understanding current and past XTANT MEDICAL Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of XTANT MEDICAL's financial statements are interrelated, with each one affecting the others. For example, an increase in XTANT MEDICAL's assets may result in an increase in income on the income statement.
XTANT MEDICAL Stock Summary
XTANT MEDICAL competes with Wyndham Hotels, Associated British, Tyson Foods, Charoen Pokphand, and Host Hotels. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. XTANT MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.Instrument | Germany Stock View All |
Exchange | Frankfurt Exchange |
ISIN | US98420P3082 |
Business Address | 664 Cruiser Lane |
Sector | Healthcare |
Industry | Medical Devices |
Benchmark | Dow Jones Industrial |
Website | www.xtantmedical.com |
Phone | 406 388 0480 |
Currency | EUR - Euro |
You should never invest in XTANT MEDICAL without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of XTANT Stock, because this is throwing your money away. Analyzing the key information contained in XTANT MEDICAL's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
XTANT MEDICAL Key Financial Ratios
There are many critical financial ratios that XTANT MEDICAL's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that XTANT MEDICAL HLDGS reports annually and quarterly.Return On Equity | -0.26 | |||
Return On Asset | -0.0619 | |||
Number Of Employees | 116 | |||
Beta | 0.63 | |||
Z Score | 2.4 |
XTANT Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XTANT MEDICAL's current stock value. Our valuation model uses many indicators to compare XTANT MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XTANT MEDICAL competition to find correlations between indicators driving XTANT MEDICAL's intrinsic value. More Info.XTANT MEDICAL HLDGS is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the XTANT MEDICAL's earnings, one of the primary drivers of an investment's value.XTANT MEDICAL HLDGS Systematic Risk
XTANT MEDICAL's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. XTANT MEDICAL volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on XTANT MEDICAL HLDGS correlated with the market. If Beta is less than 0 XTANT MEDICAL generally moves in the opposite direction as compared to the market. If XTANT MEDICAL Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one XTANT MEDICAL HLDGS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of XTANT MEDICAL is generally in the same direction as the market. If Beta > 1 XTANT MEDICAL moves generally in the same direction as, but more than the movement of the benchmark.
XTANT MEDICAL Thematic Clasifications
XTANT MEDICAL HLDGS is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Drugs | View |
XTANT MEDICAL December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of XTANT MEDICAL help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of XTANT MEDICAL HLDGS. We use our internally-developed statistical techniques to arrive at the intrinsic value of XTANT MEDICAL HLDGS based on widely used predictive technical indicators. In general, we focus on analyzing XTANT Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build XTANT MEDICAL's daily price indicators and compare them against related drivers.
Information Ratio | (0.08) | |||
Maximum Drawdown | 32.87 | |||
Value At Risk | (7.69) | |||
Potential Upside | 11.11 |
Complementary Tools for XTANT Stock analysis
When running XTANT MEDICAL's price analysis, check to measure XTANT MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTANT MEDICAL is operating at the current time. Most of XTANT MEDICAL's value examination focuses on studying past and present price action to predict the probability of XTANT MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTANT MEDICAL's price. Additionally, you may evaluate how the addition of XTANT MEDICAL to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Transaction History View history of all your transactions and understand their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |